BrandMemo | manage and share brands you love  Pharmamedix su Facebook  Pharmamedix su Twitter
 Home | News | About us | Comitato scientifico | Iscriviti | Utenti | Etica | Contenuti | Guida | Faq | Stage | Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pregabalin

Lyrica, Ecubalin e altri

Bibliografia - Quali fonti bibliografiche per Pregabalin?


         
  1. Arnold LM. et al., Curr. Med. Res. Opin., 2014, 30 (10), 2069.

  2. Arroyo S et al., Epilepsia, 2004, 45 (1), 20.

  3. Aust. Adv. Drug Reaction Bull., 2007, 26, 23.

  4. Baldwin D.S., Ajel K., Neuropsychiatr. Dis. Treat., 2007, 3 (2), 185.

  5. Bensal D. et al., Diabet. Med., 2009, 26 (10), 1019.

  6. Beydoun A. et al., Neurology, 2005, 64 (3), 475.

  7. Bockbrader H.N. et al., Epilepsia, 2002, 43 Suppl. 8, 145.

  8. Bockbrader H.N. et al., Neurology, 2004, 62 Suppl. 5, A314.

  9. Bockbrader H.N. et al., Epilepsia, 2011, 52 (2), 405.

  10. Bockbrader H.N. et al., Epilepsia, 2011a, 52 (2), 248.

  11. Corrigan B. et al., Epilepsia, 2002, 43 (Suppl. 8), 144.

  12. Crespo Perez L. et al., Med. Clin., 2008, 103, 157.

  13. Crofford L.J. et al., Arthritis Rheum., 2005, 52, 1264.

  14. Crofford L.J. et al., Pain. 2008, 136 (3), 419.

  15. De Smedt R.H. et al., Br. J. Clin. Pharmacol., 2008, 66 (2), 327.

  16. Dooley D.J. et al., Synapse, 2002, 45 (3), 171.

  17. Drug and Therapeutics Bulletin, 2006, 44(10), 73.

  18. Einarsdottir S. et al., Eur. J. Gastroenterol. Hepatol., 2008, 20, 1049.

  19. FDA, Postmarket Drug Safety Information for Patients and Providers, 2008, 31 gennaio.

  20. Filipetto F.A. et al., J. Am. Osteopath. Assoc., 2010, 110 (10), 605.

  21. Fink K. et al., Neuropharmacology, 2002, 42 (2), 229.

  22. French J.A. et al., Neurology, 2003, 60 (10), 1631.

  23. Greiner M.J. et al., Neurology, 2004, 62 Suppl. 5, 315.

  24. Guberman A. et al., Neurology, 2004, 62 Suppl. 5, 313.

  25. Hindmarch I. et al., American psychiatric Association 2002, Annual Meeting: New Research Abstract, 2002, maggio 18-23, Philadelphia, (abstract n 206 e 415).

  26. Laville M.A. et al., Rev. Med. Interne, 2008, 29 (2), 152.

  27. Lauria-Horner B.A. et al., Expert Opin. Investig. Drugs, 2003, 12 (4), 663.

  28. Lesser H. et al., Neurology, 2004.

  29. Note AIFA, Bollettino d’Informazione sui Farmaci, 2009, n 5-6.

  30. Mease P.J. et al., J. Rheumatol., 2008, 35 (3), 502.

  31. Morrell M. et al., Neurology, 2004, 62 (Suppl. 5), A314 (abstract P04.096).

  32. Oaklander A.L., Buchbinder B.R., Ann. Neurol., 2005, 58 (2), 309.

  33. Orive Calzada A. et al., Med. Clin., 2008, 131, 398.

  34. Page R.L. et al., J. Cardiovasc. Med. (Hagerstown), 2008, 9 (9), 922.

  35. Pande A.C. et al., Am. J. Psychiatry, 2003, 160, 533.

  36. Pande A.C. et al., J. Clin. Psychopharmacol., 2004, 24 (2), 141.

  37. Pohl R.B. et al., J. Clin. Psychopharmacol., 2005, 25 (2), 151.

  38. Rosenstock J. et al., Pain, 2004, 110, 628.

  39. Rowbotham M. et al., J. Pain, 2003, 4 (Suppl. i), 63 (abstract n 846).

  40. Russell I.J. et al., Sleep Med., 2009, 10 (6), 604.

  41. Scheda Prodotto LYRICA, disponibile on line http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000546/human_med_000894.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124

  42. Schwan S. et al., Eur. J. Clin. Pharmacol., 2010, 66 (9), 947.

  43. Sharma U. et al., Diabetes, 2000, 49 (Suppl. 1), 167.

  44. Sharma U. et al., 153rd American Psychiatric Association Annual Meeting, 2000a, 13-18 maggio, Chicago (abstract n NR531).

  45. Siler A.C. et al., J. Pain, 2011, 12 (4), 407.

  46. Strojek K. et al., Diabetes, 2004, 53 Suppl. 2, 59 (abstract n 804).

  47. Taylor C.P., CNS Drug Rev., 2004, 10 (2), 159.

  48. Toelle T. et al., Anasthesiology, 2004, 101, A967.

  49. Warner G., Figgitt D.P., CNS Drug, 2005, 19 (3), 265.

  50. Willmore L.J., Neurology, 2000, 55 (11 Suppl. 3), S17.

  51. Wolfe F. et al., Arthritis. Rheum., 1995, 38, 19.

  52. Wood D.M. et al., J. Med. Toxicol., 2010, 6 (4), 435.